Nuo Therapeutics secures $500K equity investment from distributor Pacific Medical; raises $4.5M YTD

Nuo Therapeutics, Inc.

PacMed invests $500K for 500K shares at $1.00; receives two warrants for up to 450K shares tied to sales quotas.
PacMed can earn up to 300K milestone shares if cumulative sales reach $4.5M–$12.5M over 2024–2025 periods.
Company raised ~$4.5M in working capital equity in 2022, including this deal, to support Aurix commercial re-launch.
Distribution network covers ~30% of U.S. population via 10 entities; PacMed contributes over 40 sales representatives.
Stock approved for OTCQB trading; uplisting to national securities exchange considered as a future option.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.